Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Atreon Orthopedics gains FDA clearance for tissue regen device

March 21, 2019 By Nancy Crotti

Startup Atreon Orthopedics said that the FDA has cleared its device designed to support the regeneration of tendon in rotator cuff injuries.

The Rotium bioresorbable wick is a synthetic scaffold that is positioned between the repaired tendon and the bone to facilitate and enhance the healing of the tendon to the bone, according to the Columbus, Ohio-based company. Atreon is a subsidiary of ParaGen Technologies, a joint venture between Nanofiber Solutions, which aids in developing the core technology, and Ikove Venture Partners, which provides operational support, market strategy and access to funding via a global network of investors.

In proprietary animal research performed at Colorado State University, results in both an acute and a chronic sheep model showed a “tremendous improvement” in the strength of the repaired tendon with the Rotium device over the tendons repaired without Rotium, the company added. Histological evaluation supported the results seen by showing the development of Sharpey’s Fibers between the tendon and the bone.

Atreon’s announcement comes after ParaGen received its first FDA clearance in 2018 for the Phoenix Wound Matrix, a product from ParaGen subsidiary RenovoDerm.

“To receive the second FDA clearance in a year, in two different clinical areas, tells us we are on the right track in developing our regeneration technology platform,” said Atreon CEO Ross Kayuha in a prepared statement. “We saw impressive success with this product in both acute and chronic animal trials, and are looking forward to how this can help people who are recovering from rotator cuff injuries.”

ParaGen recently closed a $3 million bridge funding round. Ikove Venture Partners managed and organized the round through its network of investors. About 70% of the funds came from 10 different countries.

“The milestones and accelerated success we are seeing with our regenerative medicine products are made possible through the continued supported from our global network of investors,”  said Flavio Lobato, managing partner of Ikove Venture Partners and board chairman at ParaGen.
“We are thrilled for all that’s to come.”

 

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A portrait of Stryker executive Tracy Robertson
Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
Stryker Mako robotic-arm assisted surgery robotic digital health medtech
How Stryker is advancing digital healthcare
Ariste Medical co-founder Lisa Jennings
Ariste Medical co-founder sees great potential for drug-coated implants and orthopedics

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech